1-8 of 8
Sunil R. Hingorani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma

Ingunn M. Stromnes, Adam L. Burrack, Ayaka Hulbert, Patrick Bonson, Cheryl Black, J. Scott Brockenbrough, Jackson F. Raynor, Ellen J. Spartz, Robert H. Pierce, Philip D. Greenberg, Sunil R. Hingorani
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (6): 977–989.
https://doi.org/10.1158/2326-6066.CIR-18-0448
Published: 03 June 2019
View article titled, Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma
Open the PDF for Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract IA17: Utilizing synthetic biology and high-dimensional probing to address therapeutic obstacles and empower engineered T cells with the capacity to eradicate tumors

Kristin G. Anderson, Dan Egan, Sunil R. Hingorani, Shannon K. Oda, Kelly Paulson, Rachel Perret, Leah Schmidt, Thomas Schmitt, Ingunn Stromnes, Aude Chapuis, Philip D. Greenberg
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): IA17.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-IA17
Published: 01 February 2019
View article titled, Abstract IA17: Utilizing synthetic biology and high-dimensional probing to address therapeutic obstacles and empower engineered T cells with the capacity to eradicate tumors
Journal Articles

Abstract IA02: Engineering T cells to eradicate tumors in the age of synthetic biology

Philip D. Greenberg, Kristin G. Anderson, Dan Egan, Sunil R. Hingorani, Shannon K. Oda, Rachel Perret, Tom M. Schmitt, Ingunn M. Stromnes, Leah Schmidt, Aude G. Chapuis
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (9_Supplement): IA02.
https://doi.org/10.1158/2326-6074.TUMIMM17-IA02
Published: 01 September 2018
View article titled, Abstract IA02: Engineering T cells to eradicate tumors in the age of synthetic biology
Journal Articles

T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma

Ingunn M. Stromnes, Ayaka Hulbert, Robert H. Pierce, Philip D. Greenberg, Sunil R. Hingorani
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (11): 978–991.
https://doi.org/10.1158/2326-6066.CIR-16-0322
Published: 31 October 2017
View article titled, T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma
Open the PDF for T-cell Localization, Activation, and Clonal Expansion in Human Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract IA01: Engineering T cell responses to tumors: Taking the immune system where no responses have gone before

Philip D. Greenberg, Kristin G. Anderson, Dan Egan, Sunil R. Hingorani, Shannon K. Oda, Rachel Perret, Andrea Schietinger, Tom M. Schmitt, Ingunn M. Stromnes, Alec Wilkens, Aude G. Chapuis
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): IA01.
https://doi.org/10.1158/2326-6066.IMM2016-IA01
Published: 31 October 2016
View article titled, Abstract IA01: Engineering T cell responses to tumors: Taking the immune system where no responses have gone before
Journal Articles

Abstract IA38: Engineered T cell-receptor based therapy of pancreatic ductal adenocarcinoma

Ingunn M. Stromnes, Thomas M. Schmitt, Scott J. Brockenbrough, Hieu Nguyen, Carlos Cuevas, Ayaka Hulbert, Jennifer Hotes, Ashley Dotson, Sunil R. Hingorani, Philip D. Greenberg
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): IA38.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-IA38
Published: 03 January 2016
View article titled, Abstract IA38: Engineered T cell-receptor based therapy of pancreatic ductal adenocarcinoma
Journal Articles

Abstract B20: Enhanced affinity T cell receptor based therapy can surmount immune and physical barriers to treat pancreatic ductal adenocarcinoma

Ingunn M. Stromnes, Scott J. Brockenbrough, Thomas M. Schmitt, Sunil R. Hingorani, Philip D. Greenberg
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (10_Supplement): B20.
https://doi.org/10.1158/2326-6074.TUMIMM14-B20
Published: 09 October 2015
View article titled, Abstract B20: Enhanced affinity T cell receptor based therapy can surmount immune and physical barriers to treat pancreatic ductal adenocarcinoma
Journal Articles

Abstract PR08: Enhanced affinity T cell receptor based therapy can surmount immune and physical barriers to treat pancreatic ductal adenocarcinoma

Ingunn M. Stromnes, Scott J. Brockenbrough, Thomas M. Schmitt, Sunil R. Hingorani, Philip D. Greenberg
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (10_Supplement): PR08.
https://doi.org/10.1158/2326-6074.TUMIMM14-PR08
Published: 09 October 2015
View article titled, Abstract PR08: Enhanced affinity T cell receptor based therapy can surmount immune and physical barriers to treat pancreatic ductal adenocarcinoma